Advertisement
Featured Article| Volume 19, ISSUE 5, 104550, May 2023

Assessment of Stuttering Priapism in Individuals with Sickle Cell Disease

Published:February 15, 2023DOI:https://doi.org/10.1016/j.nurpra.2023.104550

      Highlights

      • Stuttering priapism is a rare urologic condition and often starts in childhood.
      • Sickle cell disease is a common contributor of stuttering priapism.
      • Awareness of stuttering priapism is essential to avoid further complications.
      • Primary goals to manage stuttering priapism are reducing the frequency of episodes.
      • Establishing a trusting relationship is paramount for interprofessional care.

      Abstract

      Stuttering priapism is a rare and underinvestigated urologic condition reported in individuals with sickle cell disease (SCD). SCD is the most common cause of stuttering priapism. Stuttering priapism, also known as recurrent or intermittent priapism, manifests as transient, repetitive, painful episodes of prolonged erections with intermittent periods of detumescence without sexual stimulation. The tumescence or erection can result in ischemic damage to the corporal tissues. A detailed history and physical examination are paramount for interprofessional management. The nurse practitioner is in a key position to assist individuals with SCD in identification, prevention, and management of stuttering priapism.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal for Nurse Practitioners
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rees D.C.
        • Williams T.N.
        • Gladwin M.T.
        Sickle-cell disease.
        Lancet. 2010; 376: 2018-2031https://doi.org/10.1016/S0140-6736(10)61029-X
        • Piel F.B.
        • Patil A.P.
        • Howes R.E.
        • et al.
        Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model based map and population estimates.
        Lancet. 2013; 381: 142-151https://doi.org/10.1016/S0140-6736(12)61229-X
        • Shigehara K.
        • Namiki M.
        Clinical management of priapism: a review.
        World J Mens Health. 2016; 34: 1-8https://doi.org/10.5534/wjmh.2016.34.1.1
        • Donaldson J.F.
        • Rees R.W.
        • Steinbrecher H.A.
        Priapism in children: a comprehensive review and clinical guideline.
        J Pediatr Urol. 2014; 10: 11-25https://doi.org/10.1016/j.jpurol.2013.07.024
        • Anele U.A.
        • Le B.V.
        • Resar L.M.S.
        • Burnett A.L.
        How I treat priapism.
        Blood. 2015; 125: 3551-3558https://doi.org/10.1182/blood-2014-09-551887
        • Ridgley J.
        • Raison N.
        • Sheikh M.I.
        • et al.
        Ischaemic priapism: a clinical review.
        Turk J Urol. 2017; 43: 1-8https://doi.org/10.5152/tud.2017.59458
        • Hudnall M.
        • Reed-Maldonado A.B.
        • Lue T.F.
        Advances in the understanding of priapism.
        Transl Androl Urol. 2017; 6: 199-206https://doi.org/10.21037/tau.2017.01.18
        • Johnson M.
        • Parnham A.
        • Ralph D.
        Stuttering (recurrent ischemic priaprism).
        Urology News. 2018; 22
        • Kousournas G.
        • Muneer A.
        • Ralph D.
        • Xacharakis E.
        Contemporary best practice in the evaluation and management of stuttering priapism.
        Ther Adv Urol. 2017; 9: 227-238https://doi.org/10.1177/2F1756287217717913
        • Ozahata M.C.
        • Page G.P.
        • Guo Y.
        • et al.
        Clinical and genetic predictors of priapism in sickle cell disease: results from the recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study.
        J Sex Med. 2019; 16: 1988-1999https://doi.org/10.1016/j.jsxm.2019.09.012
        • Ekong A.
        • Berg L.
        • Amos R.J.
        • Tsitsikas D.A.
        Regular automated red cell exchange transfusion in the management of stuttering priapism complicating sickle cell disease.
        Br J Haematol. 2018; 180: 585-588https://doi.org/10.1111/bjh.14393
        • Johnson M.J.
        • Kristinsson S.
        • Ralph O.
        • Chiriaco G.
        • Ralph D.
        The surgical management of ischemic priapism.
        Int J Impot Res. 2020; 32: 81-88https://doi.org/10.1038/s41443-019-0197-9
        • Muneer A.
        • Ralph D.
        Guideline of guidelines: priapism.
        BJU Int. 2016; 119: 204-208https://doi.org/10.1111/bju.13717
        • Burnett A.L.
        • Sharlip I.D.
        2013. Standard operating procedures for priapism.
        J Sex Med. 2013; 10: 180-194https://doi.org/10.1111/j.1743-6109.2012.02707.x
        • Liguori G.
        • Rizzo M.
        • Boschian R.
        • et al.
        The management of stuttering priapism.
        Minerva Urol Nefrol. 2020; 72: 173-186https://doi.org/10.23736/S03932249.19.03323-X
        • Costa D.O.
        • Araújo F.A.
        • Xaviar S.A.G.
        • Araújo L.S.
        • Silva U.B.
        • Santos E.A.
        Self-care of men with priapism and sickle cell disease.
        Rev Bras Enferm. 2018; 71: 2418-2424https://doi.org/10.1590/0034-7167-2017-0464
        • Capece M.
        • Gillo A.
        • Cocci A.
        • Garaffa G.
        • Timpano M.
        • Falcone M.
        Management of refractory ischemic priapism: current perspectives.
        Res Rep Urol. 2017; 9: 175-179https://doi.org/10.2147/RRU.S128003
        • Silberman M.
        • Stormont G.
        • Hu E.W.
        Priapism.
        (Updated December 5, 2022. In: StatPearls. StatPearls Publishing. January 2022)
        https://www.ncbi.nlm.nih.gov/books/NBK459178/
        Date accessed: August 12, 2022
        • Faddan A.A.
        • Aksenov A.V.
        • Naumann C.M.
        • Jünemann K.P.
        • Osmonov D.K.
        Semi-rigid penile prosthesis as a salvage management of idiopathic ischemic stuttering priapism.
        Res Rep Urol. 2015; 7: 137-141https://doi.org/10.2147/RRU.S83361
        • Muneer A.
        • Alnajjar H.M.
        • Ralph D.
        Recent advances in the management of priapism.
        F1000Research. 2018; 7: 37https://doi.org/10.12688/2Ff1000research.12828.1
        • Bivalacqua T.J.
        • Allen B.K.
        • Brock G.
        • et al.
        Acute ischemic priapism: an AUA/SMSNA Guideline.
        J Urol. 2021; 206: 1114-1121https://doi.org/10.1097/JU.0000000000002236
        • Chinegwundoh F.I.
        • Smith S.
        • Anie K.A.
        Treatments for priapism in boys and men with sickle cell disease.
        Cochrane Database Syst Rev. 2004; 4: CD004198https://doi.org/10.1002/14651858.CD004198.pub2
        • Reddy A.G.
        • Alzweri L.M.
        • Gabrielson A.T.
        • Leinwand G.
        • Hellstrom W.J.G.
        Role of penile prosthesis in priapism: a review.
        World J Mens Health. 2018; 36: 4-14https://doi.org/10.5534/2Fwjmh.17040
        • Agrawal R.K.
        • Patel R.K.
        • Shah V.
        • Nainiwal L.
        • Trivedi B.
        Hydroxyurea in sickle cell disease: drug review.
        Indian J Hematol Blood Transfus. 2014; 30: 91-96https://doi.org/10.1007/s12288-013-0261-4
        • Levey H.
        • Segal R.
        • Bivalacqua T.
        Management of priapism: an update for clinicians.
        Ther Adv Urol. 2014; 6: 200-244https://doi.org/10.1177/1756287214542096
        • Salonia A.
        • Eardley I.
        • Giuliano F.
        • et al.
        European Association of Urology guidelines on priapism.
        Eur Urol. 2014; 65: 480-489https://doi.org/10.1016/j.eururo.2013.11.008
        • Tanabe P.
        • Spratling R.
        • Smith D.
        • Grissom P.
        • Hulihan M.
        Understanding the complications of sickle cell disease.
        Am J Nurs. 2019; 119: 26-35https://doi.org/10.1097/01.NAJ.0000559779.40570.2c

      Biography

      All authors are at the Ball State University School of Nursing, Muncie, IN. Sheila Y. Abebe, DNP, BC-FNP, is an Assistant Professor and Associate Program Director and can be reached at [email protected]

      Biography

      Elizabeth Goldsby, PhD, RN, is an Assistant Professor and teaches in the Baccalaureate Nursing Program.

      Biography

      Kalyn Renbarger, PhD, RN, is an assistant professor and Associate Baccalaureate Program Director.

      Biography

      Gabriel Hall, BA, is a graduate student.